Login or register

GlaxoSmithKline finance head banned


Chinese authorities looking into alleged bribery by GlaxoSmithKline have banned the UK drugmaker's British head of finance from leaving China.

The travel ban was imposed on Steve Nechelput at the end of June, said a company spokesperson.

On Monday, police in China said GSK had transferred 3bn yuan ($489m; £321m) to travel agencies and consultancies to facilitate bribes to doctors.

GSK has said it is deeply "concerned and disappointed" by the allegations.

Views: 296 Submitted: 07/18/2013
Hide Comments
Leave a comment Refresh Comments (0)
Anonymous comments allowed.
No comments!